Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2016 Oct;138(4):1030-1041.
doi: 10.1016/j.jaci.2016.06.059.

Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents

Affiliations
Clinical Trial

Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents

Jacqueline A Pongracic et al. J Allergy Clin Immunol. 2016 Oct.

Abstract

Background: Treatment levels required to control asthma vary greatly across a population with asthma. The factors that contribute to variability in treatment requirements of inner-city children have not been fully elucidated.

Objective: We sought to identify the clinical characteristics that distinguish difficult-to-control asthma from easy-to-control asthma.

Methods: Asthmatic children aged 6 to 17 years underwent baseline assessment and bimonthly guideline-based management visits over 1 year. Difficult-to-control and easy-to-control asthma were defined as daily therapy with 500 μg of fluticasone or greater with or without a long-acting β-agonist versus 100 μg or less assigned on at least 4 visits. Forty-four baseline variables were used to compare the 2 groups by using univariate analyses and to identify the most relevant features of difficult-to-control asthma by using a variable selection algorithm. Nonlinear seasonal variation in longitudinal measures (symptoms, pulmonary physiology, and exacerbations) was examined by using generalized additive mixed-effects models.

Results: Among 619 recruited participants, 40.9% had difficult-to-control asthma, 37.5% had easy-to-control asthma, and 21.6% fell into neither group. At baseline, FEV1 bronchodilator responsiveness was the most important characteristic distinguishing difficult-to-control asthma from easy-to-control asthma. Markers of rhinitis severity and atopy were among the other major discriminating features. Over time, difficult-to-control asthma was characterized by high exacerbation rates, particularly in spring and fall; greater daytime and nighttime symptoms, especially in fall and winter; and compromised pulmonary physiology despite ongoing high-dose controller therapy.

Conclusions: Despite good adherence, difficult-to-control asthma showed little improvement in symptoms, exacerbations, or pulmonary physiology over the year. In addition to pulmonary physiology measures, rhinitis severity and atopy were associated with high-dose asthma controller therapy requirement.

Keywords: Child; IgE; allergen sensitization; asthma; asthma exacerbations; asthma morbidity; asthma phenotype; asthma severity; inner-city asthma; pulmonary function; rhinitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic of APIC study design: Flow diagram illustrating: 1) screening visit; 2) clinic visits; 3) definition of easy-to-control, indeterminate and difficult-to-control groups based on controller treatment step throughout the study; and 4) domains used to group characteristics measured on each participant throughout the study.
Figure 2
Figure 2
CONSORT diagram: Flow diagram illustrating the number of individuals screened as well as the number of participants in the full APIC cohort and included in the analytic sample.
Figure 3
Figure 3
Controller treatment step for easy-to-control and difficult-to-control groups over 12 months. Green and blue lines (shaded areas) indicate mean (95% CI) of controller treatment step for easy-to-control and difficult-to-control groups respectively over 12 months.
Figure 4
Figure 4
Seasonal variation in clinical severity measures in easy-to-control, indeterminate and difficult-to-control groups. Green and blue lines (shaded areas) indicate mean or probability (95% CI) of clinical severity measure for easy-to-control and difficult-to-control groups respectively over 12 months. Clinical severity measures are: A) CASI component measuring day symptoms and albuterol use in the last two weeks (0 to 3 points); B) CASI component measuring night symptoms and albuterol use in the last two weeks (0 to 3 points); C) FEV1/FVC (×100); and D) Monthly incidence of exacerbations, as defined by prednisone use.
Figure 5
Figure 5
Variable importance plot of characteristics (with and without pulmonary physiology variables) distinguishing difficult-to-control from easy-to-control groups. Circles plot the median z-score for each variable, a measure of importance obtained from Boruta, a feature selection algorithm where higher values indicate a higher level of importance. Solid blue circles indicate variables that are confirmed as being relevant to distingushing difficult- from easy-to-control groups. Pink and green circle indicate variables that are tentative or rejected respectively and are not relevant to distingushing between difficult- from easy-to-control groups.

Comment in

References

    1. Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008;372:1065–72. - PMC - PubMed
    1. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol. 2003;111:1171–83. quiz 84. - PubMed
    1. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007;120:S94–138. - PubMed
    1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy. 2008;63(86):8–160. - PubMed
    1. Wildfire JJ, Gergen PJ, Sorkness CA, et al. Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents. The Journal of allergy and clinical immunology. 2012;129:694–701. - PMC - PubMed

Publication types

Substances